VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3125
ETF rank
โ‚ฌ14.79 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
20,00ย โ‚ฌ
Share price
-1.98%
Change (1 day)
4.45%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of January 2026: 0.35%